<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32236823</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-7479</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</Title><ISOAbbreviation>Neurotherapeutics</ISOAbbreviation></Journal><ArticleTitle>Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models.</ArticleTitle><Pagination><StartPage>973</StartPage><EndPage>988</EndPage><MedlinePgn>973-988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13311-020-00852-3</ELocationID><Abstract><AbstractText>While the peripheral nervous system is able to repair itself following injury and disease, recovery is often slow and incomplete, with no available treatments to enhance the effectiveness of regeneration. Using knock-out and transgenic overexpressor mice, we previously reported that BACE1, an aspartyl protease, as reported by Hemming et al. (PLoS One 4:12, 2009), negatively regulates peripheral nerve regeneration. Here, we investigated whether pharmacological inhibition of BACE may enhance peripheral nerve repair following traumatic nerve injury or neurodegenerative disease. BACE inhibitor-treated mice had increased numbers of regenerating axons and enhanced functional recovery after a sciatic nerve crush while inhibition increased axonal sprouting following a partial nerve injury. In the SOD1<sup>G93A</sup> ALS mouse model, BACE inhibition increased axonal regeneration with improved muscle re-innervation. CHL1, a BACE1 substrate, was elevated in treated mice and may mediate enhanced regeneration. Our data demonstrates that pharmacological BACE inhibition accelerates peripheral axon regeneration after varied nerve injuries and could be used as a potential therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallon</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Division, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Katherine L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Division, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Merck &amp; Co, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyde</LastName><ForeName>Lynn A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Merck &amp; Co, Kenilworth, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farah</LastName><ForeName>Mohamed H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Division, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA. mfarah2@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS079339</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotherapeutics</MedlineTA><NlmUniqueID>101290381</NlmUniqueID><ISSNLinking>1878-7479</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurotherapeutics. 2020 Jul;17(3):966-967</RefSource><PMID Version="1">32514890</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009416" MajorTopicYN="N">Nerve Regeneration</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059348" MajorTopicYN="N">Peripheral Nerve Injuries</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BACE1</Keyword><Keyword MajorTopicYN="N">Peripheral nerve repair</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegeneration.</Keyword><Keyword MajorTopicYN="N">peripheral nerve injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32236823</ArticleId><ArticleId IdType="pmc">PMC7609814</ArticleId><ArticleId IdType="doi">10.1007/s13311-020-00852-3</ArticleId><ArticleId IdType="pii">10.1007/s13311-020-00852-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gordon T. Nerve regeneration in the peripheral and central nervous systems. J Physiol. 2016;594(13):3517&#x2013;3520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929322</ArticleId><ArticleId IdType="pubmed">27365158</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheib J, Hoke A. Advances in peripheral nerve regeneration. Nat Rev Neurol. 2013;9(12):668&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217518</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH. Measuring nerve regeneration in the mouse. Exp Neurol. 2010;223(1):60&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20080088</ArticleId></ArticleIdList></Reference><Reference><Citation>Palispis WA, Gupta R. Surgical repair in humans after traumatic nerve injury provides limited functional neural regeneration in adults. Exp Neurol. 2017;290:106&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">28111229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One. 2009;4(12):e8477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2793532</ArticleId><ArticleId IdType="pubmed">20041192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402(6761):537&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Bienkowski MJ, Shuck ME, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 1999;402(6761):533&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591213</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Hicks CW, He W, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9(12):1520&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">17099708</ArticleId></ArticleIdList></Reference><Reference><Citation>Willem M, Garratt AN, Novak B, et al. Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 2006;314(5799):664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">16990514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn PH, Marjaux E, Imhof A, De Strooper B, Haass C, Lichtenthaler SF. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem. 2007;282(16):11982&#x2013;11995.</Citation><ArticleIdList><ArticleId IdType="pubmed">17307738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Bar&#xe3;o S, Laga M, et al. The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chem. 2012;287(31):25927&#x2013;25940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406677</ArticleId><ArticleId IdType="pubmed">22692213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigoni M, Wanngren J, Kuhn PH, et al. Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Mol Neurodegener. 2016;11(1):67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5053352</ArticleId><ArticleId IdType="pubmed">27716410</ArticleId></ArticleIdList></Reference><Reference><Citation>Michailov GV, Sereda MW, Brinkmann BG, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science. 2004;304(5671):700&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">15044753</ArticleId></ArticleIdList></Reference><Reference><Citation>Taveggia C, Zanazzi G, Petrylak A, et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron. 2005;47(5):681&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2387056</ArticleId><ArticleId IdType="pubmed">16129398</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah MH, Pan BH, Hoffman PN, et al. Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J Neurosci. 2011;31(15):5744&#x2013;5754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302726</ArticleId><ArticleId IdType="pubmed">21490216</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Rockenstein E, Masliah E, Farah MH. Increased BACE1 activity inhibits peripheral nerve regeneration after injury. Neurobiol Dis. 2017;106:147&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">28687442</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaisuksunt V, Campbell G, Zhang Y, Schachner M, Lieberman AR, Anderson PN. The cell recognition molecule CHL1 is strongly upregulated by injured and regenerating thalamic neurons. J Comp Neurol. 2000;425(3):382&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">10972939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Roslan R, Lang D, Schachner M, Lieberman AR, Anderson PN. Expression of CHL1 and L1 by neurons and glia following sciatic nerve and dorsal root injury. Mol Cell Neurosci. 2000;16(1):71&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">10882484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkle CL, Diestel S, Lieberman J, Maness PF. Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM) J Neurobiol. 2006;66(12):1378&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">16967505</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar&#xe3;o S, G&#xe4;rtner A, Leyva-D&#xed;az E, et al. Antagonistic Effects of BACE1 and APH1B-&#x3b3;-Secretase Control Axonal Guidance by Regulating Growth Cone Collapse. Cell Rep. 2015;12(9):1367&#x2013;1376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820248</ArticleId><ArticleId IdType="pubmed">26299962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy ME, Stamford AW, Chen X et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS &#x3b2;-amyloid in animal models and in Alzheimer's disease patients. Sci Transl Med, 8(363), 363ra150 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27807285</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan MF, Kost J, Voss T, et al. Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease. N Engl J Med. 2019;380(15):1408&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6776078</ArticleId><ArticleId IdType="pubmed">30970186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan B, Grunewald B, Nguyen T, et al. The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies. Exp Neurol. 2012;236(1):6&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367078</ArticleId><ArticleId IdType="pubmed">22361024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;28(2):154&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9(3):408&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer AM, Sanes JR, Lichtman JW. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol. 2005;490(3):209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185(2):232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20(7):2534&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M, Leclerc N, Gurney M, Warter JM, Poindron P, Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve. 1997;20(1):45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8995582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience. 2016;312:179&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Bame M, Pentiak PA, Needleman R, Brusilow WSA. Effect of Sex on Lifespan, Disease Progression, and the Response to Methionine Sulfoximine in the SOD1 G93A Mouse Model for ALS. Gender Medicine. 2012;9(6):524&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">23217569</ArticleId></ArticleIdList></Reference><Reference><Citation>May PC, Willis BA, Lowe SL, et al. The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans. J Neurosci. 2015;35(3):1199&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605527</ArticleId><ArticleId IdType="pubmed">25609634</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamford AW, Scott JD, Li SW, et al. Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS A&#x3b2; Reduction. ACS Med Chem Lett. 2012;3(11):897&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568987</ArticleId><ArticleId IdType="pubmed">23412139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal M, Wu Y, Misiaszek J, et al. Structure-Based Design of an Iminoheterocyclic &#x3b2;-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central A&#x3b2; in Nonhuman Primates. Journal of Medicinal Chemistry. 2016;59(7):3231&#x2013;3248.</Citation><ArticleIdList><ArticleId IdType="pubmed">26937601</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28(1):41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264(5166), 1772&#x2013;1775 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Wang Y, McCarthy D, et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 2001;4(3):233&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">11224536</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott JD, Li SW, Brunskill AP, et al. Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease. J Med Chem. 2016;59(23):10435&#x2013;10450.</Citation><ArticleIdList><ArticleId IdType="pubmed">27933948</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MC, Ironton R. Motor neurone sprouting induced by prolonged tetrodotoxin block of nerve action potentials. Nature. 1977;265(5593):459&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">834299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk A, Drachman D. Motor nerve sprouting and acetylcholine receptors. Science. 1978;199(4334):1223&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pubmed">204007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, He W, Diaconu C, et al. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. Faseb j. 2008;22(8):2970&#x2013;2980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493455</ArticleId><ArticleId IdType="pubmed">18413858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Hu J, Dai L, Trapp B, Yan R. Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves. J Neurosci. 2015;35(9):3806&#x2013;3814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348183</ArticleId><ArticleId IdType="pubmed">25740511</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The "dying-back" phenomenon of motor neurons in ALS. J Mol Neurosci, 43(3), 470&#x2013;477 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggers R, Tannemaat MR, De Winter F, Malessy MJ, Verhaagen J. Clinical and neurobiological advances in promoting regeneration of the ventral root avulsion lesion. Eur J Neurosci. 2016;43(3):318&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">26415525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, Amirjani N, Edwards DC, Chan KM. Brief post-surgical electrical stimulation accelerates axon regeneration and muscle reinnervation without affecting the functional measures in carpal tunnel syndrome patients. Exp Neurol. 2010;223(1):192&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">19800329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, Borschel GH. The use of the rat as a model for studying peripheral nerve regeneration and sprouting after complete and partial nerve injuries. Exp Neurol. 2017;287(Pt 3):331&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">26795087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, Hegedus J, Tam SL. Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurol Res. 2004;26(2):174&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">15072637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoke A. Neuroprotection in the peripheral nervous system: rationale for more effective therapies. Arch Neurol. 2006;63(12):1681&#x2013;1685.</Citation><ArticleIdList><ArticleId IdType="pubmed">17172606</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, Tyreman N, Raji MA. The basis for diminished functional recovery after delayed peripheral nerve repair. J Neurosci. 2011;31(14):5325&#x2013;5334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6622714</ArticleId><ArticleId IdType="pubmed">21471367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuma M, Gorski G, Sheu S-H, et al. Lack of motor recovery after prolonged denervation of the neuromuscular junction is not due to regenerative failure. European Journal of Neuroscience. 2016;43(3):451&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738060</ArticleId><ArticleId IdType="pubmed">26332731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature. 2009;457(7232):981&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677572</ArticleId><ArticleId IdType="pubmed">19225519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson JB, Hobbs C, Parsons MJ, et al. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3871&#x2013;3882.</Citation><ArticleIdList><ArticleId IdType="pubmed">22678056</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijffers R, Zhang J, Matthews JC, et al. ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation. Proc Natl Acad Sci U S A. 2014;111(4):1622&#x2013;1627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3910594</ArticleId><ArticleId IdType="pubmed">24474789</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Martinez-Muriana A, Leiva T, et al. Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1(G93A) ALS mice and after partial muscle denervation. Neurobiol Dis. 2016;95:168&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">27461051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataria H, Alizadeh A, Karimi-Abdolrezaee S. Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair. Prog Neurobiol, 101643 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31229498</ArticleId></ArticleIdList></Reference><Reference><Citation>Udina E, Putman CT, Harris LR, Tyreman N, Cook VE, Gordon T. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III. J Physiol. 2017;595(5):1815&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330916</ArticleId><ArticleId IdType="pubmed">27891608</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AR, Bobylev I, Zhang G, Sheikh KA, Lehmann HC. Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves. Exp Neurol. 2015;263:28&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">25261755</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AR, Muke I, Bobylev I, Lehmann HC. ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis. J Comp Neurol, (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30861116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bixby JL, Lilien J, Reichardt LF. Identification of the major proteins that promote neuronal process outgrowth on Schwann cells in vitro. J Cell Biol. 1988;107(1):353&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115170</ArticleId><ArticleId IdType="pubmed">3392103</ArticleId></ArticleIdList></Reference><Reference><Citation>Seilheimer B, Schachner M. Studies of adhesion molecules mediating interactions between cells of peripheral nervous system indicate a major role for L1 in mediating sensory neuron growth on Schwann cells in culture. J Cell Biol. 1988;107(1):341&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115159</ArticleId><ArticleId IdType="pubmed">3292543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>